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Abstract
Background: Celiac disease (CD) is a chronic disorder characterized by a pathological
inflammatory response after exposure to gluten in genetically susceptible individuals. The HLA
complex accounts for less than half of the genetic component of the disease, and additional genes
must be implicated. Interleukin-10 (IL-10) is an important regulator of mucosal immunity, and
several reports have described alterations of IL-10 levels in celiac patients. The IL-10 gene is located
on chromosome 1, and its promoter carries several single nucleotide polymorphisms (SNPs) and
microsatellites which have been associated to production levels. Our aim was to study the role of
those polymorphisms in susceptibility to CD in our population.
Methods: A case-control and a familial study were performed. Positions -1082, -819 and -592 of
the IL-10 promoter were typed by TaqMan and allele specific PCR. IL10R and IL10G microsatellites
were amplified with labelled primers, and they were subsequently run on an automatic sequencer.
In this study 446 patients and 573 controls were included, all of them white Spaniards. Extended
haplotypes encompassing microsatellites and SNPs were obtained in families and estimated in
controls by the Expectation-Maximization algorithm.
Results: No significant associations after Bonferroni correction were observed in the SNPs or any
of the microsatellites. Stratification by HLA-DQ2 (DQA1*0501-DQB1*02) status did not alter the
results. When extended haplotypes were analyzed, no differences were apparent either.
Conclusion: The IL-10 polymorphisms studied are not associated with celiac disease. Our data
suggest that the IL-10 alteration seen in patients may be more consequence than cause of the
disease.
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Celiac disease (CD) is a chronic inflammatory disorder
characterized by a pathological response after exposure to
gluten in genetically susceptible individuals [1]. HLA class
II genes, mainly the alleles DQA1*0501 and DQB1*02
(HLA-DQ2) but also DQA1*0301 and DQB1*0302
(HLA-DQ8), have been found to play an important role in
the development of celiac disease. However, HLA genes
do not explain the totality of CD cases detected and other
genes must be involved in CD onset. In fact, the sibling
familial risk attributed to HLA is approximately half of the
sibling risk for CD [2].
The histological lesions typical of CD seem to be associ-
ated with a predominant T helper type 1 (Th1) cell
response. Thus, cytokines characteristic of a Th1 inflam-
matory response as interferon gamma, are produced by
lamina propria T cells isolated from the intestine of CD
patients after gluten stimulation [3]. The complex home-
ostatic regulation of immune processes involves numer-
ous interacting cells and molecules. The prototypic
regulatory cytokine in the intestinal mucosa is IL-10.
Among other functions, its role as an inhibitor of Th1 cell
development should be highlighted in the context of CD.
Therefore, basal underproduction of IL-10 could eventu-
ally contribute to an exacerbated Th1 inflammation and
this, in turn, might increase CD susceptibility. In fact, low
levels of IL-10 have been found associated with different
typical features of celiac disease such as anti-tissue trans-
glutaminase antibodies [4] and studies using recom-
binant human IL-10 (rhIL-10) have shown a suppression
of gliadin-specific T cell activation [5]. IL-10 knock-out
mice develop chronic enterocolitis, and recent trials have
investigated the possibility of using IL-10 as therapy in
ulcerative colitis patients [6], another chronic inflamma-
tory disease of the intestinal mucosa.
The IL-10 gene is located on human chromosome 1 (1q31-
q32) and several polymorphisms have been described in
its regulatory region. The IL-10 promoter contains single
nucleotide polymorphisms (SNPs) in the proximal and
distal regions. The proximal SNPs are at position -1082 (A/
G), -819 (T/C) and -592 (A/C) and the strong linkage dis-
equilibrium they display makes them appear in only three
haplotypes (ACC, ATA and GCC) out of the theoretical
maximum of eight. These variants have been reportedly
involved in the transcription rate of IL-10 and therefore in
the production level of this cytokine. Two microsatellites
have been also described in the 5'-flanking region, IL10G
and IL10R, at 1.1 and 4 kb from the origin of transcription,
respectively. It has been described that haplotypes formed
by those microsatellites are associated with different levels
of IL-10 production [7]. The study of those polymor-
phisms seems then appropriate to study the possible
implication of the IL-10 gene in CD susceptibility.
Several studies have been previously performed studying
IL-10 as a candidate gene for different autoimmune or
inflammatory diseases and some associations with spe-
cific alleles have been reported. For example, the allele 12
of the IL10G microsatellite was described as associated
with multiple sclerosis [8] and rheumatoid arthritis [9],
and a similar trend was shown in type 1 diabetes [10]; in
Crohn's disease, association with IL-10G 14 and -1082G
was reported [11]. In another study, [12] no association of
IBD and proximal SNPs of IL-10 was observed, but micro-
satellites were not included.
A previous family-based study performed in Finnish pop-
ulation failed to show association between IL-10 poly-
morphisms and CD, but they studied only the promoter
SNPs and not the IL10G and IL10R microsatellites [13]. A
case-control study in Italian population again showed
negative results, but only the -1082 (A/G) promoter SNP
was analyzed in their samples [14].
Our aim was to perform a more comprehensive study
including both SNPs and microsatellites, and perform a
case-control and a family TDT analysis, in a large group of
Spanish CD patients and controls.
Methods
Subjects
A total of 446 celiac disease (CD) patients (59% women)
and 573 ethnically matched healthy controls (51%
women) recruited from the Hospital Clínico San Carlos
(Madrid, Spain) were studied to assess the influence of IL-
10 polymorphisms in the predisposition to CD. We
included parents (only one mother showed CD) of 189
patients (these were part of the above-mentioned 446 CD
patients). Fourteen of the 446 CD patients also showed
IgA deficiency. Celiac patients were diagnosed following
the European Society for Paediatric Gastroenterology and
Nutrition (ESPGAN) criteria [15]. All the samples were
obtained from Spanish white individuals after obtaining
their informed consent.
Genotyping
CD patients were genotyped for two single nucleotide pol-
ymorphisms (SNPs), -1082 (G/A) and -592 (C/A), both
located in the proximal promoter of the IL-10 gene. The
study was performed by using TaqMan probes
(C___1747360_10 for -1082 and C___1747363_10 for -
592) under conditions recommended by the manufac-
turer (Applied Biosystems, Norwalk, USA). The samples
were read by two observers and some samples with
known results were included in the analysis as controls.
Those two SNPs had been analyzed in controls using
allele-specific PCR as previously described [8]. In the con-
trol group, a third promoter polymorphism, -819 (C/T),
located between the other two SNPs, was also studied.Page 2 of 5
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quilibrium with the -1082 and -592 SNPs, and therefore
it could be always deduced in CD patients. This interme-
diate position is written between parentheses in the
present paper to remember that it was not really typed in
all samples. The equivalence between the typing per-
formed by those two different techniques was tested in 96
samples and no discrepancies were found. Two CA-repeat
microsatellites in the 5'-flanking region of the IL-10 gene,
designed as IL10R and IL10G, were also studied in CD
patients and controls as previously described. In brief, a
PCR is performed with labelled primers, and the products
were electrophoretically run on an AbiPrism 3100 auto-
matic sequencer (Applied Biosystems) [8]. HLA-DR and
HLA-DQ typing was also performed as described before
[16].
Statistical analysis
Carrier, allelic and haplotypic frequencies in patients and
controls were compared by means of chi-square tests and
Fisher's exact test when necessary (expected values below
5), using the statistical package EpiInfo v5.00 (CDC,
Atlanta, USA). The sample size in the present study would
allow us to detect an OR value of 1.5 for an allelic fre-
quency of 0.1 (at a significance level of 0.05) with a statis-
tical power, calculated using the program found online
[17], of 80%. Haplotypes were obtained by segregation
analysis in the group of CD patients with families and
they were instead estimated in the control group with the
Expectation-Maximization (EM) algorithm implemented
in the Arlequin program v2.000. Transmitted and non-
transmitted haplotypes were compared using the Trans-
mission Disequilibrium Test (TDT).
Results
The case-control comparison of the carrier frequencies of
the different alleles found in each of the two microsatel-
lites studied, IL10R and IL10G, did not show any signifi-
cant difference. Table 1 shows those values for the most
frequent alleles of each microsatellite. In one case (allele
13 of IL10G), one p-value under 0.05 was found but the
significance was lost when Bonferroni (9 comparisons)
correction was applied. The study of the promoter SNPs
showed no significant results either. The three haplotypes
formed by those three SNPs, A(C)C, A(T)A and G(C)C
were not differentially distributed when patients and con-
trols were compared (Table 2).
Extended haplotypes including the IL-10 microsatellites
and the promoter SNPs studied were also established.
Haplotype frequencies were compared between patients
and controls and also by means of a TDT in a familial
study, but no extended haplotypes were found to be asso-
ciated with or linked to CD (data not shown). Haplotypic
frequencies obtained are similar to the previously
described [18].
Table 1: Carrier frequencies in IL-10R and IL-10G microsatellites in CD patients (n = 446) and controls (n = 573)
CD patients % Controls % OR p
IL-10R
2 425 95.3 552 96.3 0.77 0.406
3 165 37.0 198 34.5 1.11 0.420
4 9 2.0 19 3.3 0.60 0.209
IL-10G
7 21 4.7 16 2.8 1.72 0.105
8 36 8.1 34 5.9 1.39 0.181
9 248 55.6 306 53.4 1.09 0.484
10 65 14.6 75 13.1 1.13 0.494
11 107 24.0 140 24.4 0.98 0.870
12 54 12.1 63 11.0 1.12 0.580
13 170 38.1 263 46.0 0.73 0.013
14 81 18.2 81 14.1 1.35 0.081
15 9 2.0 18 3.1 0.64 0.268
Table 2: Carrier frequencies of promoter SNPs haplotypes in CD patients (n = 425) and controls (n = 529)
CD patients % Controls % OR p
ACC 239 56.24 287 54.25 1.08 0.541
ATA 186 43.76 235 44.42 0.97 0.839
GCC 275 64.71 332 62.76 1.04 0.535Page 3 of 5
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(HLA-DQ2) on the development of celiac disease could
be masking a potentially weak effect of IL-10 polymor-
phisms on CD. To try to circumvent this problem, we per-
formed a stratified analysis, comparing DQ2-positive with
DQ2-negative patients (9%) and with controls, but no
significant differences were observed among those groups
(data not shown).
Discussion
In this study we have performed a case-control and a
familial study to assess the involvement of IL-10 polymor-
phisms in celiac disease. The results obtained seem to
indicate that IL-10 is not an important susceptibility
genetic factor for CD. This would seem an unexpected
result since previous studies had revealed altered cytokine
levels in several inflammatory conditions. Nevertheless,
the most consistent finding in CD patients has been an
increased production of interferon gamma, while IL-10
levels tend to remain at normal levels, although contradic-
tory results do exist [19-21]. It has been described occa-
sionally an increase in IL-10 mRNA levels in the intestine
of celiac disease patients, but it is possible that this is a
counter-regulatory mechanism triggered by the disease,
and not the cause of the pathology [21]. This interpreta-
tion is supported by the fact that after gluten removal
from the diet, IL-10 levels return to normal levels [19].
There have been few studies of IL-10 polymorphisms with
celiac disease, mostly with negative results [13,14]. A
recent report in Swedish population [4] describes an
increase in homozygous -1082 AA individuals in patients
compared to controls; we were not able to detect this
effect, although our sample size was significantly higher.
A recent study also in a Spanish population found an
increase in the frequency of the GCC promoter haplotype
when DQ2-positive patients were compared to DQ2-neg-
ative patients [22]. However, despite our considerable
sample size, we have not been able to replicate that find-
ing (41% in DQ2-positive patients vs. 42% in DQ2 nega-
tive patients). A recent Italian report has described a
combined effect of -1082 and TNF-308A polymorphism
in celiac disease [23], but although in our population an
effect of the TNF-308A polymorphism does exist [24], we
do not observe an interaction between both genes.
Albeit negative, our study extends considerably previous
reports in terms of sample size, genetic markers included
and familial haplotype analyses. Besides, our negative
result does not preclude a relevant role of IL-10 in the
pathogenesis of the disease. It may happen that the func-
tional variation ascribed to the polymorphisms we have
studied is not important in the specific cell type that pro-
duces IL-10 in the intestinal epithelium, which has been
identified variously as Th2, Th3 or T regulatory cells. Not
uncommonly, the expression of the same gene is under
control of distinct regulatory elements in different cell
types [25,26]. The possibility remains that the genetic var-
iations we have studied, and that are associated with IL-10
production in vitro using peripheral blood leukocytes
stimulated with LPS [7] or with ConA [27], may not repli-
cate adequately the situation found in the intestinal
mucosa. It has been described how gene variations in the
IL-10 gene promoter affect IL-10 production depending
on the stimulation used [28]. Additional polymorphisms,
like those located in the distal promoter region of the IL-
10 gene, may regulate the transcription rate of this
cytokine in the mucosa. In order to not confine ourselves
to the study of the already-known promoter polymor-
phism, we have included microsatellites in our research.
The highly polymorphic IL-10R and, especially, IL-10G
microsatellites are good genetic markers of the whole
extended promoter, and no association whatsoever has
been found in the present study.
Although there may be not differences in the basal level of
IL-10 in the population, it would nevertheless be impor-
tant to keep in mind the possible relevance of this
cytokine in Celiac Disease but probably as a consequence
of other immunological processes related to CD and not
as the origin of the disease.
Conclusion
Interleukin-10 polymorphisms do not seem to be





SNP: single nucleotide polymorphism.
PCR: polymerase chain reaction.
HLA: human leukocyte antigen.
Th1: T helper type 1.
RhIL-10: recombinant human IL-10.
EM algorithm: Expectation-Maximization algorithm.
TDT: Transmission Disequilibrium Test.
LPS: lipopolysaccharide.
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